ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag science policy medical devices

Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
New Medical Devices Challenge Scientists And Regulators Alike
Elizabeth Pennisi | Apr 29, 1990 | 4 min read
WASHINGTON -- Medical devices have been the most trouble-free of biotechnology's products; they have sailed smoothly through U.S. Food and Drug Administration review. But that situation is changing. These genetically engineered materials and technologies for treating and diagnosing disease are getting more complex. At the same time, Congress and the public are increasingly concerned that FDA is not being tough enough and that technology is inflating health care costs. Last month, FDA and the S
Opinion: An Explosion of Devices
Stephen C. Schimpff | Jan 28, 2013 | 3 min read
From cardiovascular problems to neurological disorders, a plethora of new medical devices are reducing the need for surgery and improving the quality and safety of healthcare.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Book Excerpt from The State of Science
Marc Zimmer | Aug 14, 2020 | 5 min read
In Chapter 13, “Trusting Experts—and the Trump Administration,” Marc Zimmer laments the communication breakdown between modern US policy makers and scientists
New US-China Tariffs Could Affect Science
Diana Kwon | Jun 27, 2018 | 3 min read
The list of imports subject to additional taxes include products used in research, but the effect of the trade dispute is still unclear.
bacteria inside a biofilm
How Bacterial Communities Divvy up Duties
Holly Barker, PhD | Jun 1, 2023 | 10+ min read
Biofilms are home to millions of microbes, but disrupting their interactions could produce more effective antibiotics.
More regulatory science: FDA chief
Bob Grant | Sep 16, 2009 | 3 min read
The US must bolster study on how to best craft regulations that bring drugs, medical devices and vaccines to market, the commissioner of the US Food and Drug Administration stressed in a speech delivered yesterday (September 16th) in Philadelphia. linkurl:Margaret Hamburg,;http://www.fda.gov/AboutFDA/CommissionersPage/default.htm the former New York City health commissioner who was named FDA commissioner earlier this year, was speaking at the annual Regulatory Affairs Professional Society confe
Illustration of newly discovered mechanism allowing kinesin to “walk” down a microtubule. A green kinesin molecule with an attached yellow fluorophore is shown passing through a blue laser as it rotates step by step along a red and purple microtubule, fueled by blue ATP molecules that are hydrolyzed into orange ADP and phosphate groups.
High-Resolution Microscope Watches Proteins Strut Their Stuff
Holly Barker, PhD | Mar 31, 2023 | 3 min read
Modification on a high-resolution fluorescent microscopy technique allow researchers to track the precise movements of motor proteins. 
Controversy Mounts Over Gene Patenting Policy
Scott Veggeberg | Apr 26, 1992 | 5 min read
Scientists in industry and academia foresee trouble as NIH persists in claiming ownership over partial sequences Date: April 27, 1992 The reviews from the scientific community remain mostly negative over the National Institutes of Health's patent application for a total of 2,722 partial human gene sequences. Academic researchers, who say they are mostly unaffected by the patenting process, nevertheless are appalled; and while some in the commercial sector of the biotech community now believe

Run a Search

ADVERTISEMENT